LAWRENCE DAVID 4
4 · ACORDA THERAPEUTICS INC · Filed Nov 12, 2020
Insider Transaction Report
Form 4
LAWRENCE DAVID
Chief Financial Officer
Transactions
- Tax Payment
Common Stock
2020-11-09$0.86/sh−1,024$881→ 14,952 total
Footnotes (1)
- [F1]Reflects the number of shares of the issuer's Common Stock that were withheld to cover tax liability in connection with settlement of restricted stock units that vested as reported on a prior Form 4.